|Appears in Collections:||Faculty of Health Sciences and Sport Journal Articles|
|Peer Review Status:||Refereed|
|Title:||Effects of central sympathetic inhibition on heart rate variability during steady-state exercise in healthy humans|
|Authors:||De, Vito Giuseppe|
Galloway, S D
Nimmo, Myra A
McMurray, John J V
heart rate variability
|Citation:||De Vito G, Galloway SD, Nimmo MA, Maas P & McMurray JJV (2002) Effects of central sympathetic inhibition on heart rate variability during steady-state exercise in healthy humans, Clinical Physiology and Functional Imaging, 22 (1), pp. 32-38.|
|Abstract:||The profound reduction in heart rate variability (HRV) that occurs during exercise is thought to be, at least in part, the result of sympathetic nervous system activation. Moxonidine is a centrally acting anti-sympathetic drug, which suppresses sympathetic nervous system outflow by stimulation of central imidazoline receptors located in the rostral ventro-lateral medulla. This study was designed to investigate the combined effects of central sympathetic inhibition with moxonidine and steady-state dynamic exercise on HRV. Ten normal males participated in a double-blind cross-over study, taking either placebo or 0·4 mg of moxonidine. The subjects were studied at rest and during steady-state exercise. HRV was measured considering both time and frequency domain parameters. As a non-linear measure, the Poincaré scatter-plot was measured and analysed quantitatively. Ventilation and gas exchange were also measured during exercise. In addition, plasma catecholamines were measured at rest and during exercise. The only parameter changed, at rest, by moxonidine was the blood pressure which was reduced. During exercise, moxonidine reduced plasma noradrenaline (NA), compared with the placebo (P<0·01). The only change observed in HRV during exercise was a significant reduction of the continuous long-term standard deviation (SD2) of the Poincaré scatter-plot of the R-R interval (P<0·05). However, the potential and prognostic significance of this result needs to be further assessed.|
|Rights:||The publisher does not allow this work to be made publicly available in this Repository. Please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author. You can only request a copy if you wish to use this work for your own research or private study.|
University of Strathclyde
University of Strathclyde
NHS Greater Glasgow & Clyde
|Galloway_CP&FI_2002.pdf||372.28 kB||Adobe PDF||Under Embargo until 31/12/2999 Request a copy|
Note: If any of the files in this item are currently embargoed, you can request a copy directly from the author by clicking the padlock icon above. However, this facility is dependant on the depositor still being contactable at their original email address.
This item is protected by original copyright
Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
If you believe that any material held in STORRE infringes copyright, please contact firstname.lastname@example.org providing details and we will remove the Work from public display in STORRE and investigate your claim.